Accelerated atherosclerosis in systemic lupus erythematosus: don't forget the devil we know!
作者信息
van Leuven Sander I, Major Amy S
机构信息
Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt Medical Center, Nashville, TN, USA.
出版信息
Rheumatology (Oxford). 2024 Jan 4;63(1):3-5. doi: 10.1093/rheumatology/kead329.
Abstract
摘要
相似文献
1
Accelerated atherosclerosis in systemic lupus erythematosus: don't forget the devil we know!
Rheumatology (Oxford). 2024 Jan 4;63(1):3-5. doi: 10.1093/rheumatology/kead329.
2
Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine.
Ann Rheum Dis. 2020 Oct;79(10):e133. doi: 10.1136/annrheumdis-2019-215799. Epub 2019 Jun 5.
3
Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud .
Ann Rheum Dis. 2020 Oct;79(10):e134. doi: 10.1136/annrheumdis-2019-215817. Epub 2019 Jul 11.
4
5
Cardiovascular disease in systemic lupus erythematosus: has the time for action come?
Curr Opin Lipidol. 2005 Oct;16(5):501-6. doi: 10.1097/01.mol.0000182533.19135.cb.
6
How to predict subclinical atherosclerosis in systemic lupus erythematosus.
Rheumatology (Oxford). 2011 May;50(5):821-3. doi: 10.1093/rheumatology/keq283. Epub 2010 Sep 5.
7
Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus.
Scand J Rheumatol. 2006 Mar-Apr;35(2):85-95. doi: 10.1080/03009740600601526.
8
Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
Nat Clin Pract Rheumatol. 2007 Oct;3(10):536-7. doi: 10.1038/ncprheum0593.
9
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?
Ann Rheum Dis. 2011 Feb;70(2):245-8. doi: 10.1136/ard.2010.133827. Epub 2010 Nov 10.
10
The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
Curr Opin Rheumatol. 2021 Mar 1;33(2):211-218. doi: 10.1097/BOR.0000000000000773.
引用本文的文献
1
Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion.
Rheumatol Adv Pract. 2025 Jun 4;9(2):rkaf048. doi: 10.1093/rap/rkaf048. eCollection 2025.
本文引用的文献
1
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.
Rheumatology (Oxford). 2024 Jan 4;63(1):50-57. doi: 10.1093/rheumatology/kead184.
2
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
Rheumatology (Oxford). 2023 Sep 1;62(9):2998-3005. doi: 10.1093/rheumatology/kead039.
3
Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
J Rheumatol. 2023 Jan;50(1):84-92. doi: 10.3899/jrheum.220279. Epub 2022 Aug 1.
4
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.
Rheumatology (Oxford). 2022 Dec 23;62(1):225-233. doi: 10.1093/rheumatology/keac259.
5
Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
Atherosclerosis. 2015 Nov;243(1):11-8. doi: 10.1016/j.atherosclerosis.2015.08.030. Epub 2015 Aug 28.
6
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ann Rheum Dis. 2014 Mar;73(3):557-66. doi: 10.1136/annrheumdis-2012-202315. Epub 2013 Feb 22.
7
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.
Ann Rheum Dis. 2012 Mar;71(3):408-14. doi: 10.1136/annrheumdis-2011-200071. Epub 2011 Sep 27.
8
Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study.
Arthritis Res Ther. 2011 Jul 20;13(4):R117. doi: 10.1186/ar3402.
9
Lupus Atherosclerosis Prevention Study (LAPS).
Ann Rheum Dis. 2011 May;70(5):760-5. doi: 10.1136/ard.2010.136762. Epub 2010 Dec 21.
10
Systemic inflammation as a risk factor for atherothrombosis.
Rheumatology (Oxford). 2008 Jan;47(1):3-7. doi: 10.1093/rheumatology/kem202. Epub 2007 Aug 16.
Zotero 插件